AWARDPURCHASE ORDEROther than small business
Purchase order 75N93023P00702ABI SCIENTIFIC INC
Overview
Award facts
- Net obligations
- $40.3K
- $40,300of $40.3K potential value
- Outlays (paid to date)
- $40.3K
- $40.3K paid of $40.3K obligated$40,300
- Period of performance
- May 31, 2023 to Jan 31, 2024
- Ended
- Modifications
- 1
- Latest action Jun 28, 2023
- Contract type
- Purchase order
- PIID 75N93023P00702
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
ABI SCIENTIFIC BRANDED CELL GROWTH ENHANCERS & CELL MEDIUMS (AMBIS #2174676)
Dates and value
- Award date
- Signed on May 31, 2023
- Potential end of performance
- Jan 30, 2024
- Current value
- $40,300Base and exercised options
- Potential value (if all options are exercised)
- $40,300
Obligations by fiscal year of action
- FY2023: $40,300
Total across 1 fiscal year: $40,300
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 28, 2023. View on USAspending · Recipient on SAM.gov
Recipient
LocationSTERLING, VA
UEILQ8TFKUZN5Z1
CAGE code76V83
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyABI SCIENTIFIC INC
Business types and certifications
Minority-ownedFor-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Sterling, Loudoun County, Virginia 20164-6604
- Congressional district (place of performance)
- VA-10As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Not competed under SAPG
- Reason not competed
- SAP non-competition (FAR 13)SP2
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- NOI-NIAID-23-2174676
- Notices
- Presolicitation posted May 17, 2023
Contract details
- Subcontracting plan
- Plan not included - no subcontracting possibilitiesA
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- May 31, 2023Base obligation at award: $40,300
- Latest action
- Jun 28, 2023 — Supplemental agreement (within scope)Modification P00001
- Latest substantive action
- Jun 28, 2023 — Supplemental agreement (within scope)Modification P00001
- Actions by type
- Base award1
- Supplemental agreement (within scope)1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg in U.S.D
Structure
- Award or IDV
- Award
- Award type
- Purchase orderB
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2020/2024-0885-000
- Object classes
- 22.0: Transportation of things
- 26.0: Supplies and materials
- Disaster or emergency funding (DEFC)
- L: Emergency P.L. 116-123
- COVID-19 supplemental obligations
- $40,300
- COVID-19 supplemental outlays
- $40,300